See also this year's filing and all EDGAR filings for this company.
PDF Report 0000906709_2017_NEKTAR_THERAPEUTICS.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Revenues', 'missing_ratio': 0.3171617611246631, 'aggregate_val': 165436000, 'exp_sum': 242277000, 'exp_to_value': {'remainder_Revenues': 242277000}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000906709, NEKTAR THERAPEUTICS
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 426,252,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 76,501,000 |
| 2 | PropertyPlantAndEquipmentNet | 65,601,000 |
| 3 | remainder_Assets | 517,000 |
| 4 | LiabilitiesCurrent | 72,222,000 |
| 5 | LiabilitiesNoncurrent | 5,000,000 |
| 6 | remainder_Liabilities | 403,524,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 44,275,000 |
| 9 | ResearchAndDevelopmentExpense | 203,801,000 |
| 10 | remainder_Expenses | 31,091,000 |
| 11 | remainder_Revenues | 165,436,000 |
| 12 | remainder_NetIncome | -39,793,000 |
| 13 | remainder_ComprehensiveNetIncome | -193,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 568,871,000 |
| 1 | Liabilities | 480,746,000 |
| 2 | Expenses | 279,167,000 |
| 3 | Revenues | 165,436,000 |
| 4 | StockholdersEquity | 88,125,000 |
| 5 | NetIncome | -153,524,000 |
| 6 | ComprehensiveNetIncome | -153,620,500 |
| 7 | BaseVar | 767,103,000 |
| 8 | EconomicCapitalRatio | -0.00390 |
Edgar->Model Mapping
Feature Distribution
